| dbo:abstract |
Secbutabarbital (INN), auch Butabarbital (USAN), ist ein Barbiturat. Chemisch betrachtet ist es ein Barbitursäure-Derivat. Secbutabarbital wurde 1932 für Eli Lilly and Company patentiert. (de) Butabarbital (brand name Butisol) is a prescription barbiturate sleep aid and anxiety medication. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia, relieving general anxiety and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its intermediate duration of action gives butabarbital an abuse potential slightly lower than secobarbital. Butabarbital can be hydrolyzed to Valnoctamide. Butabarbital is also sold in combination with belladonna alkaloids under the brand name Butibel. The belladonna is added for antispasmodic effect. This product contains a low dose of butabarbital combined with a standardised mix of belladonna alkaloids and is used as an antispasmodic taken to relieve cramping and spasms of the stomach and intestines. They are used also to decrease the amount of acid formed in the stomach. Another similar product is Donnatal, which contains belladonna alkaloids combined with phenobarbital. (en) Sekbutabarbital, butabarbital – organiczny związek chemiczny stosowany jako lek z grupy barbituranów. Jest objęty Konwencją o substancjach psychotropowych z 1971 roku (wykaz IV). W Polsce jest w grupie IV-P Ustawy o przeciwdziałaniu narkomanii. (pl) Butabarbital é um fármaco da classe dos barbitúricos com ação curta ou intermediária. Um dos nomes comerciais para esta substância é Butisol. (pt) |
| dbo:alternativeName |
Butisol (en) |
| dbo:casNumber |
125-40-6 |
| dbo:chEBI |
3228 |
| dbo:chEMBL |
449 |
| dbo:drugbank |
DB00237 |
| dbo:fdaUniiCode |
P0078O25A9 |
| dbo:kegg |
D03180 |
| dbo:medlinePlus |
a682417 |
| dbo:pubchem |
2479 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Butabarbital_Formula_V1.svg?width=300 |
| dbo:wikiPageExternalLink |
https://druginfo.nlm.nih.gov/drugportal/rn/125-40-6 |
| dbo:wikiPageID |
2680804 (xsd:integer) |
| dbo:wikiPageLength |
15791 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1121605888 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Bayer dbr:Bradycardia dbr:Deadly_nightshade dbc:Barbiturates dbr:Antispasmodic dbr:Valnoctamide dbr:Anxiety dbr:Barbiturate dbr:Phenobarbital dbr:Insomnia dbr:Secobarbital dbr:Sedative dbr:File:(R)-Butabarbital_Formula_V1.svg dbr:File:(S)-Butabarbital_Formula_V1.svg |
| dbp:atcPrefix |
none (en) |
| dbp:c |
10 (xsd:integer) |
| dbp:casNumber |
125 (xsd:integer) |
| dbp:chebi |
3228 (xsd:integer) |
| dbp:chembl |
449 (xsd:integer) |
| dbp:chemspiderid |
2385 (xsd:integer) |
| dbp:dailymedid |
Butabarbital (en) |
| dbp:drugbank |
DB00237 (en) |
| dbp:eliminationHalfLife |
100 (xsd:integer) |
| dbp:excretion |
Urine (en) |
| dbp:h |
16 (xsd:integer) |
| dbp:iupacName |
5 (xsd:integer) |
| dbp:iupharLigand |
7137 (xsd:integer) |
| dbp:kegg |
D03180 (en) |
| dbp:legalCa |
Schedule IV (en) |
| dbp:legalDe |
Anlage II (en) |
| dbp:legalUs |
Schedule III (en) |
| dbp:medlineplus |
a682417 (en) |
| dbp:n |
2 (xsd:integer) |
| dbp:o |
3 (xsd:integer) |
| dbp:pubchem |
2479 (xsd:integer) |
| dbp:smiles |
O=C1NCNCC1CC (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
ZRIHAIZYIMGOAB-UHFFFAOYSA-N (en) |
| dbp:synonyms |
Butabarbital, Butisol (en) |
| dbp:tradename |
Butisol (en) |
| dbp:unii |
P0078O25A9 (en) |
| dbp:verifiedrevid |
443491373 (xsd:integer) |
| dbp:width |
155 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Cite_web dbt:Div_col dbt:Div_col_end dbt:Drugbox dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Use_dmy_dates dbt:When dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Drugs.com dbt:Barbiturates |
| dcterms:subject |
dbc:Barbiturates |
| gold:hypernym |
dbr:Aid |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Lighthouse yago:WikicatUreas yago:Abstraction100002137 yago:Base114618253 yago:Chemical114806838 yago:Compound114818238 yago:Imide115110666 yago:Material114580897 yago:Matter100020827 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Pyrimidine114999913 yago:Relation100031921 yago:WikicatImides dbo:Drug yago:Substance100019613 yago:Urea115085472 yago:WikicatPyrimidines umbel-rc:DrugProduct |
| rdfs:comment |
Secbutabarbital (INN), auch Butabarbital (USAN), ist ein Barbiturat. Chemisch betrachtet ist es ein Barbitursäure-Derivat. Secbutabarbital wurde 1932 für Eli Lilly and Company patentiert. (de) Sekbutabarbital, butabarbital – organiczny związek chemiczny stosowany jako lek z grupy barbituranów. Jest objęty Konwencją o substancjach psychotropowych z 1971 roku (wykaz IV). W Polsce jest w grupie IV-P Ustawy o przeciwdziałaniu narkomanii. (pl) Butabarbital é um fármaco da classe dos barbitúricos com ação curta ou intermediária. Um dos nomes comerciais para esta substância é Butisol. (pt) Butabarbital (brand name Butisol) is a prescription barbiturate sleep aid and anxiety medication. Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia, relieving general anxiety and relieving anxiety before surgical procedures; however it is also relatively dangerous particularly when combined with alcohol, and so is now rarely used, although it is still prescribed in some Eastern European and South American countries. Its intermediate duration of action gives butabarbital an abuse potential slightly lower than secobarbital. Butabarbital can be hydrolyzed to Valnoctamide. (en) |
| rdfs:label |
Butabarbital (en) Secbutabarbital (de) Sekbutabarbital (pl) Butabarbital (pt) |
| owl:sameAs |
freebase:Butabarbital http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00237 yago-res:Butabarbital wikidata:Butabarbital dbpedia-cy:Butabarbital dbpedia-de:Butabarbital dbpedia-fi:Butabarbital dbpedia-gl:Butabarbital dbpedia-hr:Butabarbital dbpedia-pl:Butabarbital dbpedia-pt:Butabarbital dbpedia-ro:Butabarbital dbpedia-sh:Butabarbital dbpedia-sr:Butabarbital dbpedia-vi:Butabarbital https://global.dbpedia.org/id/3pBPW |
| prov:wasDerivedFrom |
wikipedia-en:Butabarbital?oldid=1121605888&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/(R)-Butabarbital_Formula_V1.svg wiki-commons:Special:FilePath/(S)-Butabarbital_Formula_V1.svg wiki-commons:Special:FilePath/Butabarbital_Formula_V1.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Butabarbital |
| is dbo:wikiPageRedirects of |
dbr:Buta-barbital dbr:Butabarb dbr:Butalan dbr:Butatab dbr:Butatal dbr:Buticaps dbr:Butisol dbr:Butisol_Sodium dbr:Sarisol dbr:Sarisol_No._1 dbr:Medarsed dbr:Unicelles dbr:Nilox dbr:Butabarbital_sodium dbr:Secbutabarbital dbr:Secbutabarbital_sodium dbr:Secbutobarbitone |
| is dbo:wikiPageWikiLink of |
dbr:List_of_compounds_with_carbon_number_10 dbr:Misuse_of_Drugs_Act_(Singapore) dbr:Buta-barbital dbr:Butabarb dbr:Butalan dbr:Butatab dbr:Butatal dbr:Buticaps dbr:Butisol dbr:Butisol_Sodium dbr:C10H16N2O3 dbr:Valnoctamide dbr:Decree-Law_15/93 dbr:Controlled_Drugs_and_Substances_Act dbr:Convention_on_Psychotropic_Substances dbr:Sarisol dbr:Sarisol_No._1 dbr:Barbiturate dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:GABAA_receptor_positive_allosteric_modulator dbr:McNeil_Consumer_Healthcare dbr:Medarsed dbr:Unicelles dbr:Nilox dbr:Butabarbital_sodium dbr:Secbutabarbital dbr:Secbutabarbital_sodium dbr:Secbutobarbitone |
| is foaf:primaryTopic of |
wikipedia-en:Butabarbital |
